Every year, roughly 80,000 Americans receive a bladder cancer diagnosis. Many endure difficult and burdensome treatments in an attempt to fight the disease. But new innovations just might change that.
A Hematologist explains bispecific antibodies in myeloma treatment
PVI, PeerView Institute for Medical Education on LinkedIn: Making an Impact in Bladder Cancer Care: Integrating the Latest Evidence…
Janssen's global head of R&D opens up on CAR-T research, data science and more - Drug Discovery and Development
FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation
Johnson & Johnson on LinkedIn: Dr. Paul Janssen Award
Michael J. Morris, MD - MSK Genitourinary Oncologist
Rectal Cancer Disappears After Experimental Use of Immunotherapy
A biomarker led approach to bladder cancer - ecancer
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
Bladder Cancer, Causes of Incontinence
Advances in immunotherapies and targeted treatments for patients with bladder cancer: An update from ESMO 2022 - touchONCOLOGY
Is it possible to cure bladder cancer?
